ArticleInsights into imaging2021
Cost-effectiveness of artificial intelligence aided vessel occlusion detection in acute stroke: an early health technology assessment.
Article in Insights into imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 4 syntheses or guidelines pooled it, 58 citations in OpenAlex.
- Cost-effectiveness of artificial intelligence tools in radiology: a systematic review.European radiology · 2026Pooled it
- Economic evaluation of AI-assisted technologies in healthcare: A systematic review.Journal of food and drug analysis · 2025Pooled it
- Software with artificial intelligence-derived algorithms for analysing CT brain scans in people with a suspected acute stroke: a systematic review and cost-effectiveness analysis.Health technology assessment (Winchester, England) · 2024Pooled it
- Economic evaluations of artificial intelligence-based healthcare interventions: a systematic literature review of best practices in their conduct and reporting.Frontiers in pharmacology · 2023Pooled it
- Cost-effectiveness of apixaban vs. aspirin for the reduction of thrombo-embolism in high-risk patients with device-detected atrial fibrillation: insights from the ARTESiA trial.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025Trial
- Evaluation of standardized DICOM labels assigned by a hybrid AI tool and its impact on radiologists' reading times.European radiology · 2026Article
- Assessing the Value for Money of AI-Assisted Technologies for Older Adults: Scoping Review of Economic Evaluations.Journal of medical Internet research · 2026Article
- Article
- Transforming Stroke Diagnosis with Artificial Intelligence: A Scoping Review of Brainomix e-Stroke, Aidoc, RapidAI, and Viz.ai.Medicina (Kaunas, Lithuania) · 2026Article
- Artificial intelligence in hepatopathy diagnosis and treatment: Big data analytics, deep learning, and clinical prediction models.World journal of gastroenterology · 2025Review
- Evaluation of a Deep Learning Tool for Detecting Large Vessel Occlusion and Intracranial Hemorrhage on Noncontrast Computed Tomography Scans.Stroke (Hoboken, N.J.) · 2025Article
- Economic Evaluations and Equity in the Use of Artificial Intelligence in Imaging Examinations for Medical Diagnosis in People With Dermatological, Neurological, and Pulmonary Diseases: Systematic Review.Interactive journal of medical research · 2025Review
- Commercialization of medical artificial intelligence technologies: challenges and opportunities.NPJ digital medicine · 2025Article
- ESR Essentials: how to get to valuable radiology AI: the role of early health technology assessment-practice recommendations by the European Society of Medical Imaging Informatics.European radiology · 2025Review
- Artificial intelligence for diagnostics in radiology practice: a rapid systematic scoping review.EClinicalMedicine · 2025Article
- Economic value of AI-based MRI triage for Parkinson's disease: a cost-benefit study in South Korea and the United States.Frontiers in public health · 2025Article
- Artificial intelligence, machine learning, and reproducibility in stroke research.European stroke journal · 2024Article
- Artificial intelligence support in MR imaging of incidental renal masses: an early health technology assessment.European radiology · 2024Article
- Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI).Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2024Article
- Challenges and Potential of Artificial Intelligence in Neuroradiology.Clinical neuroradiology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLimited evidence is available on the clinical impact of artificial intelligence (AI) in radiology. Early health technology assessment (HTA) is a methodology to assess the potential value of an innovation at an early stage. We use early HTA to evaluate the potential value of AI software in radiology. As a use-case, we evaluate the cost-effectiveness of AI software aiding the detection of intracranial large vessel occlusions (LVO) in stroke in comparison to standard care. We used a Markov based model from a societal perspective of the United Kingdom predominantly using stroke registry data complemented with pooled outcome data from large, randomized trials. Different scenarios were explored by varying missed diagnoses of LVOs, AI costs and AI performance. Other input parameters were varied to demonstrate model robustness. Results were reported in expected incremental costs (IC) and effects (IE) expressed in quality adjusted life years (QALYs).
resultsApplying the base case assumptions (6% missed diagnoses of LVOs by clinicians, $40 per AI analysis, 50% reduction of missed LVOs by AI), resulted in cost-savings and incremental QALYs over the projected lifetime (IC: - $156, - 0.23%; IE: + 0.01 QALYs, + 0.07%) per suspected ischemic stroke patient. For each yearly cohort of patients in the UK this translates to a total cost saving of $11 million.
conclusionsAI tools for LVO detection in emergency care have the potential to improve healthcare outcomes and save costs. We demonstrate how early HTA may be applied for the evaluation of clinically applied AI software for radiology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.